BeStock  
Stocks › Medical Devices › AXGN

AxoGen AXGN

US equityMarket cap rank #2355Medical Devices
$55.75 −$0.60 (-1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.10 +0.63%
Open$55.71
Prev close$56.35
Day range$55.03 – $56.91
Volume876.1K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

AXGN at a glance

Shares of AxoGen are down 1.06% at $55.75. The company is worth $3.33B, number 2355 out of 3753 on our list.

Over the past 52 weeks it has traded between $26.92 and $59.72, so it sits 6.6% below the top of that range. Holders are ahead 107.5% over twelve months, and up 13.2% across the last three months.

On the chart it holds above both the 50-day ($44.34) and 200-day ($41.06) moving averages; RSI is 66, and the last 30 sessions moved at roughly 95% annualized volatility.

For the quarter ended Sep 2026 it reported $75.83M in revenue, up 26.2% from a year earlier, with $2.33M of net profit (a -12.0% margin).

11 analysts follow the stock and the average call is "buy". The mean target, $58.18, sits 4.4% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$55.76 / $57.58
Average price today$55.76
Volume876.1KAvg (90d) 1.42M
Turnover$48.85M
Turnover rate1.60%of shares outstanding
Volume ratio0.61vs. recent average pace
Day amplitude3.34%
Market cap$3.33B
Float market cap$3.04B
Shares outstanding54.61M
EPS (TTM)-$0.34
P/B6.71
Book value / share$8.31
Net profit (TTM)-$20.31M
Net assets$496.12M
30-day volatility95.1%annualized
Avg daily range (ATR)5.38%of price, 14 days
Max drawdown (1y)-33.1%-4.9% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

A
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 56.3 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth56.4
Profitability27.3
Momentum97.3
Financial health41.7
Analyst view40.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$58.18+4.4% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$44.93Price is above fair value

Wall Street’s average 12-month target is $58.18, 4.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $44.93, so shares trade 24.1% above that estimate. On earnings multiple, it sits in the 14th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.1%
1 week
-0.3%
1 month
+52.0%
3 months
+13.2%
6 months
+36.3%
Year to date
+70.3%
1 year
+107.5%
Day range
$55.03$56.91
52-week range
$26.92$59.72

Technical signals

Full technicals →
Trend readStrong uptrend

7 bullish · 0 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+8.8%Bullish
Price vs 50-day average+25.7%Bullish
Price vs 200-day average+35.8%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)66.4Bullish
MACD (12,26,9)3.92Bullish
Bollinger band position70%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How AXGN ranks on BeStock

Market value#2346 of 3734
Closeness to 52-week high#318 of 3724
Dollar volume today#1436 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

AXGN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on AXGN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on AXGN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

AXGN stock: common questions

What is AXGN's latest share price?

$55.75 is the latest print for AXGN, a move of -1.06% against yesterday's close of $56.35. Today's low and high so far: $55.03 and $56.91.

How large is AxoGen by market value?

Equity value comes to $3.33B at the current price. By that measure it is number 2355 of the 3753 names in our coverage.

Is AXGN near its 52-week high or low?

The year's floor is $26.92 and the ceiling $59.72. Shares are 6.6% away from that ceiling.

Does AxoGen pay a dividend?

Our data shows no dividend paid by AxoGen over the trailing twelve months.

Is AXGN rated a buy by Wall Street?

Of 11 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $58.18, with the most cautious at $48.00 and the most optimistic at $65.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on AXGN.

Sign in to join the discussion.

Scroll to Top